Navigation Links
Ampio Responds to Levi & Korsinsky, LLP Press release/solicitation
Date:11/19/2013

GREENWOOD VILLAGE, Colo., Nov. 19, 2013 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) CEO, Michael Macaluso, remarked "We are not aware of any basis for an investigation of Ampio. We note that the law firm's press release/solicitation does not contain any facts whatsoever that would explain why they are conducting an investigation.  Any objective review of Ampio's promising clinical trial results and subsequent stock performance achieved over the past year will conclude that the company is performing well.  Consequently we believe this provocative solicitation is not intended to benefit shareholders and we encourage all interested parties to form their own conclusions about the motivation behind this law firm's actions."

(Logo: http://photos.prnewswire.com/prnh/20120516/MM09116LOGO)

About Ampio Pharmaceuticals

Ampio Pharmaceuticals, Inc. is a development stage biopharmaceutical company primarily focused on the development of therapies to treat prevalent inflammatory conditions for which there are limited treatment options. We are developing compounds that decrease inflammation by (i) inhibiting specific pro-inflammatory compounds by affecting specific pathways at the protein expression and at the transcription level; (ii) activating specific phosphatase or depletion of the available phosphate needed for the inflammation process; and (iii) decreasing vascular permeability.

Forward Looking Statements

Ampio's statements in this press release that are not historical fact and that relate to future plans or events are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by use of words such as "believe," "expect," "plan," "anticipate," and similar expressions. These forward-looking st
'/>"/>

SOURCE Ampio Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Ampio Pharmaceuticals Awarded Canadian Composition of Matter Patent That Strengthens IP Protection for Its Key Drug Ampion™
2. Champions Oncology Inc. Receives Approval from U.S. Regulatory Authorities
3. Champions Oncology Reports Financial Results for the Year Ended April 30, 2012
4. Ampio Pharmaceuticals, Inc. (AMPE) announces appointment of Josh Disbrow as Chief Operating Officer effective December 15, 2012
5. Amarantus Appoints Super Bowl Champion Toi Cook to Board of Advisors to Advance TBI Program
6. CSL Behring Partners with Pro Supercross Racer Carl Schlacht to Encourage Those with Primary Immunodeficiency to be a "ChamPIon"
7. Champions Oncology Reports Financial Results for the Quarter Ended October 31, 2012
8. North Carolina A&T State University Crowned Champion in $100,000 ACC Clean Energy Challenge
9. Ampio Pharmaceuticals Announces Participation at the UBS Global Healthcare Conference
10. GenoSpace Founder and CEO Receives "Champions of Change" Award from White House
11. Olympic Champion and Health and Fitness Advocate Dara Torres Partners with Vestiage
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... W. R. Grace & Co. (NYSE: ... Germany has received good manufacturing practice (GMP) certification ... Pharmaceutical Excipient Council (IPEC) Foundation. , ... FP brand of pharmaceutical grade excipient silica gels ... Bay, Maryland (USA) and Sorocaba, Brazil locations. The ...
(Date:5/21/2015)... Research and Markets ( http://www.researchandmarkets.com/research/84975r/2015_global ... "2015 Global Survey on Flow Cytometry Adoption Trends" ... primary goal of this research is to analyze ... Key information the survey seeks to collect include ... predominantly used applications for flow cytometers, respondents, most ...
(Date:5/20/2015)... 20, 2015 Veracyte, Inc . ... demonstrating the ability of the company,s molecular classifier ... other interstitial lung diseases (ILDs) using samples obtained ... to help thousands of patients avoid invasive, risky ... diagnosis – a frequent challenge for physicians and ...
(Date:5/20/2015)... MECHANICSBURG, Pa. , May 20, 2015 /PRNewswire/ ... announced that the Federal Trade Commission granted early ... (HSR) Antitrust Improvements Act of 1976, as amended, ... by MJ Acquisition Corporation, a joint venture that ... XII, L.P. As previously announced, MJ ...
Breaking Biology Technology:Grace European Facility Receives GMP Excipient Certification for SYLOID® FP Silica Gel 2Global Survey on Flow Cytometry Adoption Trends 2015 2Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 2Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 3Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 4Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 5Select Medical Corporation's Proposed Acquisition of Concentra Inc. through Joint Venture with Welsh Carson Receives Antitrust Clearance 2
... in national survey by InformationWeek ,Without a doubt, ... is better use of their information technology. , ,No ... customized intranets, or streamlined manufacturing software, IT is the ... makes inclusion on the most recent InformationWeek 500 list ...
... are still going on in the Midwest at places like the ... news story on Monday. There are many experts giving opinions about ... many jobs are going overseas for cheaper wages and most stop ... to stop because many companies are so focused on the bottom ...
... industries are a major strength of the State of ... of the state. These industries reflect a concentration ... and devices. Concentration of this knowledge and know-how, ... services in the device and technology arena. Exceptional ...
Cached Biology Technology:Wisconsins Business IT Innovators 2Spend Money to Make Money and Dump Obsolete Tech Strategies 2Spend Money to Make Money and Dump Obsolete Tech Strategies 3Spend Money to Make Money and Dump Obsolete Tech Strategies 4
(Date:5/11/2015)... , May 11, 2015  Synaptics Incorporated (NASDAQ: ... interface solutions, today announced the appointment of ... Chief Financial Officer, reporting to Rick Bergman ... current Chief Financial Officer, Kathleen Bayless , ... Mr. Ali brings extensive financial management ...
(Date:5/7/2015)... 7, 2015 Fingerprint Cards ... and FPC1035, FPC,s smallest touch fingerprint sensors to ... considered for integration on the backside of the ... increased possibilities to integrate touch fingerprint sensors in ... improves possibilities for module manufacturers to customize the ...
(Date:4/27/2015)... , Apr. 27, 2015 Profile Solutions, Inc. ... and security systems is pleased to announce that Dr ... a consultant and member of its scientific advisory board. ... known as a thought leader in technology-enhanced learning models. ... Group, and has published studies and books focused on ...
Breaking Biology News(10 mins):Synaptics Appoints Wajid Ali as Senior Vice President and Chief Financial Officer 2FPC Introduces its Smallest Touch Fingerprint Sensors to Date 2Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 2Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 4
... Children with Duchenne muscular dystrophy (DMD) face a future ... respiratory or cardiac failure before their 30th birthday. While researchers ... effective treatment, few have targeted the heart of the problem ... new $2.1 million grant he received from the National Institutes ...
... Studies on genetically engineered mice show that social stress ... atherosclerosis. Commonly used drugs to reduce blood pressure, however, ... a thesis presented at the University of Gothenburg, Sweden. ... is a correlation between psychosocial stress and the risk ...
... Sledge Jr., M.D., a nationally recognized pioneer in the ... the 2010 William L. McGuire Memorial Lecture Award at ... Supported by GlaxoSmithKline Oncology (GSK) since its inception ... for their significant contributions to breast cancer research. ...
Cached Biology News:New NIH grant helps MU scientist get to the heart of muscular dystrophy 2Social stress leads to atherosclerosis 2George W. Sledge, Jr., M.D., honored for international contributions to breast cancer research 2
Rabbit polyclonal to Kallikrein 1 ( Abpromise for all tested applications). Antigen: Full length native kallikrein from tissue (Human) Entrez Gene ID: 3816 Swiss Protein ID: P06870...
Purified anti-mouse Tim-1...
EDG-1CT (endothelial cell differentiation gene-1, C terminal)...
Mouse Anti-human CD11b/Mac-1alpha, clone LM2/1, Monoclonal Antibody...
Biology Products: